The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2016

Filed:

Oct. 23, 2012
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Byung-Kwon Choi, Norwich, VT (US);

Stephen R. Hamilton, Enfield, NH (US);

Natarajan Sethuraman, Hanover, NH (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12P 19/18 (2006.01); C12P 21/00 (2006.01); C07K 14/62 (2006.01); C07K 16/10 (2006.01); C07K 16/32 (2006.01); C07K 14/39 (2006.01); C07K 14/395 (2006.01); C12N 9/10 (2006.01); C07K 14/47 (2006.01); C07K 16/00 (2006.01); C12N 15/81 (2006.01);
U.S. Cl.
CPC ...
C12P 21/005 (2013.01); C07K 14/39 (2013.01); C07K 14/395 (2013.01); C07K 14/4725 (2013.01); C07K 14/62 (2013.01); C07K 16/00 (2013.01); C07K 16/1027 (2013.01); C07K 16/32 (2013.01); C12N 9/1051 (2013.01); C12N 15/815 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/41 (2013.01); Y02P 20/52 (2015.11);
Abstract

Methods for increasing the yield and N-glycosylation site occupancy of paucimannose or complex N-glycans of recombinant glycoproteins produced in a recombinant host cell lacking dolichyl-P-Man:Man5GlcNAc2-PP-dolichyl alpha-1,3 mannosyltransferase (Alg3p) activity are disclosed. In particular, recombinant host cells are provided that comprise a disruption of the expression of an OS-9 family gene in the host cell. These recombinant host cells may then be used for producing recombinant glycoproteins. In further embodiments, the recombinant host cells further overexpress at least one heterologous single-subunit oligosaccharyltransferase, which in particular embodiments is capable of functionally suppressing the lethal phenotype of a mutation of at least one essential protein of the yeast oligosaccharyltransferase (OTase) complex.


Find Patent Forward Citations

Loading…